Gowda Ramesh M, Misra Deepika, Tranbaugh Robert F, Ohki Takao, Khan Ijaz A
Division of Cardiology, Beth Israel Medical Center, New York, NY, USA.
Chest. 2003 Aug;124(2):714-9. doi: 10.1378/chest.124.2.714.
The treatment of descending thoracic aortic aneurysms using endovascular stents is one of the more recent advances in treatment and is receiving increasing attention as it is a less invasive alternative to open surgical repair. Although the technology is still primitive, significant improvements have lately been made in the design and deployment of the endovascular stent-grafts. Aortic stent-grafts were used initially to exclude abdominal, and later thoracic, aortic true and false aneurysms. These prostheses have been increasingly used to treat aneurysms, dissections, and traumatic ruptures of the descending thoracic aorta with good early and mid-term outcomes. Although the long-term outcome of patients with aneurysms of the descending thoracic aorta after stent graft implantation has not been investigated, continued refinement of the endovascular approaches has decreased the need for conventional open thoracic aortic aneurysm repair, especially in patients who are at a high risk for standard surgery because of advanced age or the presence of comorbid diseases. The placement of endoluminal stent-grafts to exclude the dissected or ruptured site of thoracic aortic aneurysms is a technically feasible and relatively safe procedure. With the rapid development of endovascular approaches, the treatment of the descending thoracic aortic aneurysms might alter even more, but an extended follow-up is necessary to determine the longer term outcome. Historical perspectives, advantages, device considerations, complications, and current perspectives of the endovascular stent grafting of the descending thoracic aortic aneurysms are elaborated on.
使用血管内支架治疗降主动脉瘤是近年来治疗方面的进展之一,由于它是开放性手术修复的一种侵入性较小的替代方法,因此受到越来越多的关注。尽管这项技术仍很原始,但最近在血管内支架移植物的设计和部署方面已取得了显著进展。主动脉支架移植物最初用于排除腹主动脉真性和假性动脉瘤,后来也用于排除胸主动脉的此类动脉瘤。这些假体越来越多地用于治疗降主动脉瘤、夹层和创伤性破裂,早期和中期效果良好。尽管尚未对植入支架移植物后降主动脉瘤患者的长期预后进行研究,但血管内治疗方法的不断完善减少了传统开放性胸主动脉瘤修复的需求,尤其是对于因年龄较大或存在合并疾病而进行标准手术风险较高的患者。放置腔内支架移植物以排除胸主动脉瘤的夹层或破裂部位是一种技术上可行且相对安全的手术。随着血管内治疗方法的迅速发展,降主动脉瘤的治疗可能会发生更大的变化,但需要进行长期随访以确定长期预后。本文阐述了降主动脉瘤血管内支架植入术的历史背景、优势、器械考量、并发症及当前观点。